In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0 a new company low.

Within Biotechnology & Pharmaceuticals industry 142 other companies have achieved higher Quick Ratio than Brainstorm Cell Therapeutics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3839 to 4517.

Explain Quick Ratio?
How much Cash & cash equivalents BCLI�s has?
What are BCLI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BCLI Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	45.23 %	7.92 %	22.6 %	27.41 %	10.88 %
Y / Y Cash & cash equivalent Change	-97.33 %	-99.09 %	-84.49 %	-97.02 %	-76.25 %
Quick Ratio MRQ	0	0	0	0	0.1
BCLI's Total Ranking	# 4517	# 3839	# 4214	# 3743	# 2843
Seq. Current Liabilities Change	5.28 %	6.88 %	21.99 %	5.8 %	-21.77 %
Seq. Cash & cash equivalent Change	46.67 %	-48.28 %	480 %	-99.39 %	-49.88 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 143
Healthcare Sector	# 923
Overall Market	# 4517

Quick Ratio Statistics
High	Average	Low
11.85	3.14	0
(Sep 30 2017)		(Sep 30 2025)

Financial Statements
Brainstorm Cell Therapeutics Inc 's Current Liabilities	$ 12 Millions	Visit BCLI's Balance sheet
Brainstorm Cell Therapeutics Inc 's Cash & cash equivalent	$ 0 Millions	Visit BCLI's Balance sheet
Source of BCLI's Sales		Visit BCLI's Sales by Geography

Cumulative Brainstorm Cell Therapeutics Inc 's Quick Ratio

BCLI's Quick Ratio for the trailling 12 Months

BCLI Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	24.49 %	16.36 %	29.03 %	27.3 %	23.9 %
Y / Y Cash & cash equivalent TTM Growth	-97.48 %	-84.03 %	-45.64 %	-53.46 %	-59.47 %
Quick Ratio TTM	0	0.02	0.06	0.07	0.08
Total Ranking TTM	# 4207	# 2958	# 3164	# 3011	# 2781
Seq. Current Liabilities TTM Growth	9.57 %	2.19 %	5.42 %	5.47 %	2.42 %
Seq. Cash & cash equivalent TTM Growth	-91.87 %	-65.11 %	-5.94 %	-5.77 %	-48.37 %

Quick ratio ranking by company, industry and sector >> Back to BCLI Financial Strength Comparisons >> Go to Compare BCLI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $12.39 millions, cumulative Quick Ratio decreased to 0 below the Brainstorm Cell Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 145 other companies have achieved higher Quick Ratio than Brainstorm Cell Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2958 to 4207.

Explain Quick Ratio?
How much Cash & cash equivalents BCLI�s has?
What are BCLI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 146
Healthcare Sector	# 921
Within the Market	# 4207

trailing twelve months Quick Ratio Statistics
High	Average	Low
10.18	2.78	0
(Jun 30 2017)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Brainstorm Cell Therapeutics inc	0.00	$ 0.022 Millions	$ 12.385 Millions
Cel sci Corporation	0.00	$ 0.008 Millions	$ 5.080 Millions
Scilex Holding Company	0.00	$ 0.581 Millions	$ 512.242 Millions

Date modified: 2026-09-08T16:44:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.